{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:02:45Z","timestamp":1762430565108,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clgc.2011.06.002","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T02:31:18Z","timestamp":1315621878000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduction of Treatment Volume and Radiation Doses to Surrounding Tissues With Intraprostatic Gold Markers in Prostate Cancer Radiotherapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Johan F.","family":"Langenhuijsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Jan","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.W.","family":"Louwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van Kollenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes H.A.M.","family":"Kaanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile N.J. Th.","family":"van Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2011.06.002_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib2","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2011.06.002_bib4","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2000.18.23.3904","article-title":"Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer","volume":"18","author":"Pollack","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(01)01453-5","article-title":"Organ motion and its management","volume":"50","author":"Langen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2008.12.073","article-title":"ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate","volume":"74","author":"Michalski","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.urology.2007.10.011","article-title":"Technique for implantation of fiducial markers in the prostate","volume":"71","author":"Shinohara","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2011.06.002_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.urology.2008.10.071","article-title":"Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy","volume":"73","author":"Linden","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2011.06.002_bib10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2008.09.043","article-title":"Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment","volume":"74","author":"Gauthier","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.radonc.2008.09.005","article-title":"Off-line setup corrections only marginally reduce the number of on-line corrections for prostate radiotherapy using implanted gold markers","volume":"90","author":"van der Vight","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2006.09.034","article-title":"Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy","volume":"67","author":"van Lin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-8140(01)00452-2","article-title":"Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers","volume":"61","author":"Wu","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-8140(03)00078-1","article-title":"Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation","volume":"67","author":"Dehnad","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0360-3016(03)00076-2","article-title":"Feasibility of insertion\/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy","volume":"56","author":"Shirato","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2005.02.022","article-title":"Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging","volume":"63","author":"Schallenkamp","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(03)00267-0","article-title":"(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device","volume":"56","author":"Pouliot","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0360-3016(03)00328-6","article-title":"Marker seed migration in prostate localization","volume":"56","author":"Poggi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijrobp.2007.04.009","article-title":"Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors","volume":"69","author":"Langenhuijsen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2010.02.027","article-title":"Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life","volume":"96","author":"Moman","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2011.06.002_bib22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2005.10.002","article-title":"Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer","volume":"64","author":"Peeters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib23","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ijrobp.2006.07.1386","article-title":"Radiation proctopathy in the treatment of prostate cancer","volume":"66","author":"Garg","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2008.03.015","article-title":"Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer?","volume":"73","author":"Chung","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0360-3016(02)02857-2","article-title":"High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients","volume":"53","author":"Zelefsky","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2011.06.002_bib26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:19:43Z","timestamp":1761563983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767311000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1558767311000188"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2011.06.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Treatment Volume and Radiation Doses to Surrounding Tissues With Intraprostatic Gold Markers in Prostate Cancer Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2011.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}